Remove 2008 Remove Clinical Research Remove Research
article thumbnail

The Chemistry Clicked: Two NIH-Supported Researchers Win 2022 Nobel Prize in Chemistry

NIH Director's Blog: Drug Development

Through the years, NIH has supported a total of 169 researchers who have received or shared 101 Nobel Prizes. This form of chemistry has made it possible for researchers to snap together, like LEGO pieces, molecular building blocks to form hybrid biomolecules, often with easy-to-track imaging agents attached.

article thumbnail

Syneos Health Appoints Michael Bonello as Chief Financial Officer

The Pharma Data

Bonello has more than 30 years of financial leadership experience, including 15 years in the clinical research industry. a clinical trial data collection company, since 2021. From 2008 to 2021, Mr. Bonello held roles of increasing responsibility at Nasdaq-listed PRA Health Sciences, Inc.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The History and Development of Pinnacle 21

Quanticate

By the end of 2007, and towards the beginning of 2008, the Clinical Data Interchange Standards Consortium (CDISC) gained ground in its mission to develop a global set of standards. Gathering all the heterogenous data and mapping to the internal standards of the pharma companies proved to be the greatest challenge of the time.

article thumbnail

Human neuronal cells: possibilities in drug safety testing

Drug Target Review

Human derived induced pluripotent stem cells (hiPSCs) have revolutionised research and are increasingly used for toxicology screening and disease modelling. 27,28 Since the advent of hiPSC technology almost two decades ago enormous progress has been made in many areas of research. 2008 Mar;153 Suppl 2(Suppl 2):S1-209.

Drugs 111
article thumbnail

The Evolution of Digital Patient Portals: Enhancing Healthcare Access and Engagement

Vial

In 2022, the global market value of patient portals within the clinical research and healthcare industries was estimated to be US $2.9 In 2008, prior to ARRA and the HITECH Act, only 10% of hospitals in the United States had transitioned from paper-based methods into EMRs, primarily due to their exorbitant set-up costs.

article thumbnail

BioSpace Movers & Shakers, Dec. 18

The Pharma Data

He previously spent more than a decade at Medtronic in the company ’ s Minimally Invasive Therapies Group where he served as the global vice president and General Manager of General Surgery, and in various roles working on research, development, and strategy. He spent 27 years at Merck & Co. Immune Regulation – U.K.-based

article thumbnail

BioSpace Movers & Shakers, Nov. 6

The Pharma Data

Horizon Therapeutics – Karin Rosén joined Ireland-based Horizon Therapeutics as executive vice president, research and development and chief scientific officer. Taveras will lead all research and non-clinical development functions supporting the company’s pipeline of investigational therapies. medical affairs at GlaxoSmithKline.